Statement of Beneficial Ownership

BIODESIX INC Filed 2025-05-15 Acc 0000950170-25-072726

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

2026-01-13 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-15 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-13 4 Chief Accounting Officer sold 224 shares at an average $0.36 ($80)
2025-05-13 4 Chief Development Officer sold 445 shares at an average $0.36 ($158)
2025-05-13 4 Chief Commercial Officer sold 477 shares at an average $0.36 ($170)
2025-05-13 4 President & CEO sold 3,775 shares at an average $0.36 ($1,344)
2025-05-13 4 CFO, Sec'y & Treasurer sold 992 shares at an average $0.36 ($353)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…